Theracal Pulpotomy in Primary Molars

Ain Shams University

Status and phase: Completed; Phase 4

Conditions: Deep Caries

Treatments: Drug: Formocresol; Drug: Theracal LC

Study type: Interventional

Funder types: Other

Identifiers

NCT04397094

FDASU-Rec ID 101612

Details and patient eligibility

About

Light cured silicate based cement (theracal LC) pulpotomy was compared to formocresol pulpotomy in primary molars.

Full description

sixty primary molars were either treated with Theracal LC or formocresol pulpotomy. Teeth were followed up clinicaly and radiographically for 12 months.

Enrollment: 60 patients

Sex: All

Ages: 4 to 7 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy, cooperative children
• mandibular primary molars with vital pulp exposures

Exclusion criteria

• clinical or radiographic evidence of irreversible pulpitis
• physiological root resorption

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 2 patient groups

Theracal LC

Experimental group

Description:

Theracal LC was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months.

Treatment:

Drug: Theracal LC

Formocresol

Active Comparator group

Description:

Formocresol was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months.

Treatment:

Drug: Formocresol